Bash CN - Search Results

1

Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis.

Richert ND, Ostuni JL, Bash CN, Leist TP, McFarland HF, Frank JA. Richert ND, et al. Among authors: bash cn. Mult Scler. 2001 Feb;7(1):49-58. doi: 10.1177/135245850100700109. Mult Scler. 2001. PMID: 11321194

2

Interferon beta results in immediate reduction of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI.

Calabresi PA, Stone LA, Bash CN, Frank JA, McFarland HF. Calabresi PA, et al. Among authors: bash cn. Neurology. 1997 May;48(5):1446-8. doi: 10.1212/wnl.48.5.1446. Neurology. 1997. PMID: 9153489

3

Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b.

Calabresi PA, Tranquill LR, Dambrosia JM, Stone LA, Maloni H, Bash CN, Frank JA, McFarland HF. Calabresi PA, et al. Among authors: bash cn. Ann Neurol. 1997 May;41(5):669-74. doi: 10.1002/ana.410410517. Ann Neurol. 1997. PMID: 9153530 Clinical Trial.

4

MRI studies of multiple sclerosis: implications for the natural history of the disease and for monitoring effectiveness of experimental therapies.

McFarland HF, Stone LA, Calabresi PA, Maloni H, Bash CN, Frank JA. McFarland HF, et al. Among authors: bash cn. Mult Scler. 1996 Nov;2(4):198-205. doi: 10.1177/135245859600200406. Mult Scler. 1996. PMID: 9345374 Clinical Trial.

5

Serial whole-brain magnetization transfer imaging in patients with relapsing-remitting multiple sclerosis at baseline and during treatment with interferon beta-1b.

Richert ND, Ostuni JL, Bash CN, Duyn JH, McFarland HF, Frank JA. Richert ND, et al. Among authors: bash cn. AJNR Am J Neuroradiol. 1998 Oct;19(9):1705-13. AJNR Am J Neuroradiol. 1998. PMID: 9802494 Free PMC article. Clinical Trial.

6

MRI and clinical activity in MS patients after terminating treatment with interferon beta-1b.

Richert ND, Zierak MC, Bash CN, Lewis BK, McFarland HF, Frank JA. Richert ND, et al. Among authors: bash cn. Mult Scler. 2000 Apr;6(2):86-90. doi: 10.1177/135245850000600206. Mult Scler. 2000. PMID: 10773853 Clinical Trial.

7

Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNbeta-1b.

Rao AB, Richert N, Howard T, Lewis BK, Bash CN, McFarland HF, Frank JA. Rao AB, et al. Among authors: bash cn. Neurology. 2002 Sep 10;59(5):688-94. doi: 10.1212/wnl.59.5.688. Neurology. 2002. PMID: 12221158 Clinical Trial.

8

The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis.

Stone LA, Frank JA, Albert PS, Bash C, Smith ME, Maloni H, McFarland HF. Stone LA, et al. Ann Neurol. 1995 May;37(5):611-9. doi: 10.1002/ana.410370511. Ann Neurol. 1995. PMID: 7755356 Clinical Trial.

9

Contrast-enhanced magnetic resonance activity in relapsing remitting multiple sclerosis patients: a short term natural history study.

Bagnato F, Tancredi A, Richert N, Gasperini C, Bastianello S, Bash C, McFarland H, Pozzilli C, Frank JA. Bagnato F, et al. Mult Scler. 2000 Feb;6(1):43-9. doi: 10.1177/135245850000600109. Mult Scler. 2000. PMID: 10694845

10

A pilot study of recombinant insulin-like growth factor-1 in seven multiple sderosis patients.

Frank JA, Richert N, Lewis B, Bash C, Howard T, Civil R, Stone R, Eaton J, McFarland H, Leist T. Frank JA, et al. Mult Scler. 2002 Feb;8(1):24-9. doi: 10.1191/1352458502ms768oa. Mult Scler. 2002. PMID: 11936485 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters